CD19-CAR-NK cells show ability to initiate diverse mechanisms of cancer cell death in hematological malignancies
Annette Moter(Goethe University Frankfurt), Evelyn Ullrich(Goethe University Frankfurt), Ernst R. Schwarz(Saarland University), Markus Hoth(Saarland University), Tobias Bexte(Goethe University Frankfurt), Philipp Wendel(Goethe University Frankfurt), Nadja Küchler(Saarland University), Michael Hudecek(Lighthouse Guild), Lea Kaschek(Saarland University)
Cited by 0
Related Papers
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for <i>In Vivo</i> Antitumor Activity
|Cancer Immunology Research|2014|517
Calcium microdomains at the immunological synapse: how ORAI channels, mitochondria and calcium pumps generate local calcium signals for efficient T‐cell activation
|The EMBO Journal|2011|211
ROR1-CAR T cells are effective against lung and breast cancer in advanced microphysiologic 3D tumor models
|JCI Insight|2019|192
Inhibition of TGF-β-receptor signaling augments the antitumor function of ROR1-specific CAR T-cells against triple-negative breast cancer
|Journal for ImmunoTherapy of Cancer|2020|142
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
|Bone Marrow Transplantation|2019|119